English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Feb 4, 2026

Experimental peptide developed at Hebrew University shows promise for treating recurring epilepsy

Patient Daily | Feb 4, 2026

Oregon State University team develops nanomaterial for targeted cancer cell destruction

Patient Daily | Feb 4, 2026

Japanese scientists identify compound that could help reset body’s internal clock

Patient Daily | Feb 4, 2026

Study finds daily beef consumption does not increase type 2 diabetes risk factors

Patient Daily | Feb 4, 2026

Researchers use routine MRI scans for non-invasive advanced heart failure assessment

Patient Daily | Feb 4, 2026

Study links eating foods high in melatonin to reduced rates of obesity and depression

Patient Daily | Feb 4, 2026

Lifetime heavy drinking increases colorectal cancer risk according to new US study

Patient Daily | Feb 4, 2026

Exploring targeted protein degradation as an emerging tool against antimicrobial resistance

Trending

+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'

+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'

+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'

+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study

  • « First
  • «
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily